Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D003875:Drug Eruptions / Q000209:etiology; D004892:Erythema Multiforme / Q000139:chemically induced; D005260:Female; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D011739:Pyrimethamine / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013413:Sulfadoxine / Q000009:adverse effects* / Q000627:therapeutic use; D013424:Sulfanilamides / Q000009:adverse effects*; D014195:Travel
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine